Systematic Analysis of the Expression and Prognostic Value of ITPR1 and Correlation with Tumor Infiltrating Immune Cells in Breast Cancer

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2022 Mar 22

PMID 35313846

Authors

Bing Han

Fang Zhen

Xiu-Shuang Zheng

Jing Hu

Xue-Song Chen

Affiliations

Soon will be listed here.

Abstract

Background: ITPR1 is a key gene for autophagy, but its biological function is still unclear, and there are few studies on the correlation between ITPR1 gene expression and the occurrence and development of breast cancer.

Methods: Analyze the expression of ITPR1 through online databases such as Oncomine and TIMER. Kaplan-Meier plotter and other databases were used to evaluate the impact of ITPR1 on clinical prognosis. The expression of ITPR1 in analysis of 145 cases of breast cancer and 30 cases of adjacent normal tissue was detected by Immunohistochemistry. Statistical analysis was used to evaluate the clinical relevance and prognostic significance of abnormally expressed proteins. And the Western Blot was used to detect the expression of ITPR1 between breast cancer tissues and cells. The TIMER database studied the relationship between ITPR1 and cancer immune infiltration. And used the ROC plotter database to predict the response of ITPR1 to chemotherapy, endocrine therapy and anti-HER2 therapy in patients with breast cancer.

Results: Compared with normal breast samples, ITPR1 was significantly lower in patients with breast cancer. And the increased expression of ITPR1 mRNA was closely related to longer overall survival (OS), distant metastasis free survival (DMFS), disease specific survival (DSS) and relapse free survival (RFS) in breast cancer. And the expression level of ITPR1 was higher in patients treated with chemotherapy than untreated patients. In addition, the expression of ITPR1 was positively correlated with related gene markers of immune cells in different types of breast cancer, especially with BRCA basal tissue breast cancer.

Conclusion: ITPR1 was lower expressed in breast cancer. The higher expression of ITPR1 suggested favorable prognosis for patients. ITPR1 was related to the level of immune infiltration, especially in BRCA-Basal patients. All research results indicated that ITPR1 might affect breast cancer prognosis and participate in immune regulation. In short, ITPR1 might be a potential target for breast cancer therapy.

Citing Articles

Identification of ITPR1 gene as a novel target for hsa-miR-34b-5p in non-obstructive azoospermia: a Ca/apoptosis pathway cross-talk.

Maleki B, Modarres P, Salehi P, Vallian S Sci Rep. 2023; 13(1):21873.

PMID: 38072953 PMC: 10710998. DOI: 10.1038/s41598-023-49155-5.

Whole-genome resequencing to explore genome‑wide single nucleotide polymorphisms and genes associated with avian leukosis virus subgroup J infection in chicken.

Li H, Chen Y 3 Biotech. 2023; 13(12):417.

PMID: 38031589 PMC: 10682322. DOI: 10.1007/s13205-023-03834-2.

-associated spinocerebellar ataxia with craniofacial features-additional evidence for germline mosaicism.

Kleyner R, Ung N, Arif M, Marchi E, Amble K, Gavin M Cold Spring Harb Mol Case Stud. 2023; 9(4).

PMID: 37821226 PMC: 10815276. DOI: 10.1101/mcs.a006303.

References

De Young G, Keizer J . A single-pool inositol 1,4,5-trisphosphate-receptor-based model for agonist-stimulated oscillations in Ca2+ concentration. Proc Natl Acad Sci U S A. 1992; 89(20):9895-9. PMC: 50240. DOI: 10.1073/pnas.89.20.9895. View

Jezequel P, Gouraud W, Ben Azzouz F, Guerin-Charbonnel C, Juin P, Lasla H . bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database (Oxford). 2021; 2021. PMC: 7904047. DOI: 10.1093/database/baab007. View

Baker M, Fan G, Serysheva I . Structure of IPR channel: high-resolution insights from cryo-EM. Curr Opin Struct Biol. 2017; 46:38-47. PMC: 5683905. DOI: 10.1016/j.sbi.2017.05.014. View

Bartha A, Gyorffy B . TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021; 22(5). PMC: 7961455. DOI: 10.3390/ijms22052622. View

Resende R, Andrade L, Oliveira A, Guimaraes E, Guatimosim S, Leite M . Nucleoplasmic calcium signaling and cell proliferation: calcium signaling in the nucleus. Cell Commun Signal. 2013; 11(1):14. PMC: 3599436. DOI: 10.1186/1478-811X-11-14. View

Gyorffy B, Lanczky A, Eklund A, Denkert C, Budczies J, Li Q . An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2009; 123(3):725-31. DOI: 10.1007/s10549-009-0674-9. View

Tariq Khan M, Wagner 2nd L, Yule D, Bhanumathy C, Joseph S . Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J Biol Chem. 2005; 281(6):3731-7. DOI: 10.1074/jbc.M509262200. View

Leal F, Liutti V, Antunes dos Santos V, Figueiredo M, Macedo L, Junior J . Neoadjuvant endocrine therapy for resectable breast cancer: A systematic review and meta-analysis. Breast. 2015; 24(4):406-12. DOI: 10.1016/j.breast.2015.03.004. View

Worley P, Baraban J, Colvin J, Snyder S . Inositol trisphosphate receptor localization in brain: variable stoichiometry with protein kinase C. Nature. 1987; 325(7000):159-61. DOI: 10.1038/325159a0. View

10.

Nadif Kasri N, Bultynck G, Sienaert I, Callewaert G, Erneux C, Missiaen L . The role of calmodulin for inositol 1,4,5-trisphosphate receptor function. Biochim Biophys Acta. 2002; 1600(1-2):19-31. DOI: 10.1016/s1570-9639(02)00440-5. View

11.

Wang L, Wagner 2nd L, Alzayady K, Yule D . Region-specific proteolysis differentially regulates type 1 inositol 1,4,5-trisphosphate receptor activity. J Biol Chem. 2017; 292(28):11714-11726. PMC: 5512067. DOI: 10.1074/jbc.M117.789917. View

12.

Feriod C, Oliveira A, Guerra M, Nguyen L, Mitchell Richards K, Jurczak M . Hepatic Inositol 1,4,5 Trisphosphate Receptor Type 1 Mediates Fatty Liver. Hepatol Commun. 2017; 1(1):23-35. PMC: 5613674. DOI: 10.1002/hep4.1012. View

13.

Decuypere J, Bultynck G, Parys J . A dual role for Ca(2+) in autophagy regulation. Cell Calcium. 2011; 50(3):242-50. DOI: 10.1016/j.ceca.2011.04.001. View

14.

Yang J, Vais H, Gu W, Foskett J . Biphasic regulation of InsP3 receptor gating by dual Ca2+ release channel BH3-like domains mediates Bcl-xL control of cell viability. Proc Natl Acad Sci U S A. 2016; 113(13):E1953-62. PMC: 4822637. DOI: 10.1073/pnas.1517935113. View

15.

Motzer R, Escudier B, Mcdermott D, George S, Hammers H, Srinivas S . Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015; 373(19):1803-13. PMC: 5719487. DOI: 10.1056/NEJMoa1510665. View

16.

Patel S, Joseph S, Thomas A . Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium. 1999; 25(3):247-64. DOI: 10.1054/ceca.1999.0021. View

17.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

18.

Messai Y, Noman M, Hasmim M, Escudier B, Chouaib S . HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis. Oncoimmunology. 2015; 4(2):e985951. PMC: 4404821. DOI: 10.4161/2162402X.2014.985951. View

19.

Mizuno H, Kitada K, Nakai K, Sarai A . PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009; 2:18. PMC: 2689870. DOI: 10.1186/1755-8794-2-18. View

20.

Han B, Sun Y, Yang D, Zhang H, Mo S, Chen X . USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression. Aging (Albany NY). 2020; 12(8):6990-7005. PMC: 7202522. DOI: 10.18632/aging.103056. View